Clinical Trials Logo

Filter by:
NCT ID: NCT00134095 Active, not recruiting - Gastric Cancer Clinical Trials

S-1 and Irinotecan in Treating Patients Who Are Undergoing Surgery for Locally Advanced Stomach Cancer

Start date: September 2004
Phase: Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as S-1 and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving chemotherapy before surgery may shrink the tumor so that it can be completely removed. PURPOSE: This phase II trial is studying how well giving S-1 together with irinotecan works in treating patients who are undergoing surgery for locally advanced stomach cancer.

NCT ID: NCT00133328 Active, not recruiting - Hypertension Clinical Trials

A Morbidity-Mortality and Remodeling Study With Valsartan

Start date: January 2002
Phase: Phase 4
Study type: Interventional

The JIKEI HEART Study has been designed to investigate whether concomitant treatment with valsartan, an angiotensin II receptor blocker (ARB), in addition to conventional treatment, will improve the prognosis of 3000 Japanese patients with cardiovascular diseases.

NCT ID: NCT00133302 Terminated - Clinical trials for Non-Hodgkin's Lymphoma

Study of Standard CHOP Versus Biweekly CHOP in Aggressive Non-Hodgkin's Lymphoma (JCOG9809)

Start date: February 1999
Phase: Phase 3
Study type: Interventional

The purpose of this trial is to investigate the clinical benefit of the dose intensified regimen, Bi-CHOP in comparison to standard CHOP for advanced intermediate or high grade non-Hodgkin's lymphoma (NHL).

NCT ID: NCT00132665 Completed - Clinical trials for Non-Small-Cell Lung Carcinoma

Trial to Evaluate Radiotherapy With or Without CBDCA in Elderly Patients With Non-Small Cell Lung Cancer (JCOG0301)

Start date: July 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate whether radiotherapy with carboplatin will result in longer survival than radiotherapy alone in elderly patients with unresectable stage III NSCLC.

NCT ID: NCT00132639 Completed - Pulmonary Neoplasms Clinical Trials

Study of Preoperative Docetaxel or Cisplatin (CDDP) + Docetaxel for C-stage IB-II Non-Small Cell Lung Cancer (NSCLC)

Start date: October 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of the preoperative docetaxel and docetaxel-cisplatin combination in c-stage IB/II NSCLC, and select the optimal preoperative therapy for phase III trials.

NCT ID: NCT00132613 Completed - Clinical trials for Malignant Pericardial Effusion

Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion

Start date: August 1999
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy of pericardial instillation of bleomycin as a sclerosing agent after pericardial drainage for lung cancer-associated malignant pericardial effusion.

NCT ID: NCT00132054 Completed - Lung Cancer Clinical Trials

Amrubicin and Irinotecan in Treating Patients With Recurrent or Relapsed Extensive Stage Small Cell Lung Cancer

Start date: May 2004
Phase: Phase 1
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as amrubicin and irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of amrubicin when given together with irinotecan in treating patients with recurrent or relapsed extensive stage small cell lung cancer.

NCT ID: NCT00131846 Completed - Hypertension Clinical Trials

Diuretics In the Management of Essential Hypertension (DIME) Study

Start date: April 2004
Phase: Phase 4
Study type: Interventional

The purpose of DIME is to evaluate the safety (i.e. new onset of diabetes and other metabolic adverse events), efficacy and cost-effectiveness of antihypertensive treatment with low dose diuretics. The researchers' hypothesis is that use of low dose thiazide diuretics is metabolically safe when used with other appropriate antihypertensives, effective in reduction of blood pressure and cheaper than treatment without diuretics. Therefore, this study is an equivalence trial.

NCT ID: NCT00131053 Recruiting - Clinical trials for Lymphoblastic Leukemia, Acute

Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Start date: September 2002
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety for treating adult ALL patients with the pediatric protocol.

NCT ID: NCT00131027 Recruiting - Clinical trials for Lymphoblastic Leukemia, Acute

High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL)

Start date: September 2002
Phase: Phase 3
Study type: Interventional

The purpose of this study is to investigate the clinical efficacy of high-dose methotrexate consolidation therapy for adult patients with BCR-ABL-negative ALL.